What are the major opportunities in the Juvenile Macular Degeneration Treatment market? What are the strategies for the Juvenile Macular Degeneration Treatment market?

For detailed insights on the major opportunities and strategies in the Juvenile Macular Degeneration Treatment market, Read More

How does the Juvenile Macular Degeneration Treatment market relate to the overall economy and other similar markets?

For detailed insights on Juvenile Macular Degeneration Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Juvenile Macular Degeneration Treatment market growth? SWOT analysis of the Juvenile Macular Degeneration Treatment market.

For detailed insights on the key dynamics influencing the Juvenile Macular Degeneration Treatment market growth and SWOT analysis of the Juvenile Macular Degeneration Treatment industry, Read More

Global Juvenile Macular Degeneration Treatment Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Juvenile Macular Degeneration Treatment Global Market Report 2025

Name: Juvenile Macular Degeneration Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Wet Age-Related Macular Degeneration, Dry Age-Related Macular Degeneration), By Treatment (Devices, Drugs, Surgery), By Application (Vision Preservation, Disease Management, Symptom Relief, Preventive Care, Clinical Trials), By Sales Channel (Hospitals, Ambulatory Surgical Centres, Other Sales Channel) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Juvenile Macular Degeneration Treatment Market Overview

• Juvenile Macular Degeneration Treatment market size has reached to $1.28 billion in 2024

• Expected to grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Rising Retinal Disorders Driving The Growth Of The Market Due To Increasing Diabetes Prevalence

• Market Trend: Innovative Gene Therapies Advance Treatment Options For Stargardt Disease

• North America was the largest region in 2024.

What Is Covered Under Juvenile Macular Degeneration Treatment Market?

Juvenile macular degeneration (stargardt disease) treatment refers to a range of strategies aimed at managing vision loss and improving quality of life for individuals affected by this genetic eye disorder. It is caused by genetic mutations that damage the macula, the central part of the retina, leading to gradual vision loss and difficulty with tasks like reading and recognizing faces.

The main types of juvenile macular degeneration treatment are wet age-related macular degeneration and dry age-related macular degeneration. Wet age-related macular degeneration refers to a condition where abnormal blood vessels grow beneath the retina, leading to fluid or blood leakage and rapid central vision loss. Juvenile macular degeneration treatments include devices, drugs, and surgery. The associated applications encompass vision preservation, disease management, symptom relief, preventive care, and clinical trials, and these treatments are distributed through various channels such as hospitals, ambulatory surgical centers, and others.

Juvenile Macular Degeneration Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Juvenile Macular Degeneration Treatment Market Size 2025 And Growth Rate?

What Is The Juvenile Macular Degeneration Treatment Market Growth Forecast?

The juvenile macular degeneration treatment market size is expected to see strong growth in the next few years. It will grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to a rise in the geriatric population, a rise in ophthalmic biotechnology startups, an increasing focus on targeted drug delivery systems, an increasing number of clinical trials, and increasing investment in gene therapy. Major trends in the forecast period include advancements in genetic testing, the development of gene therapies, stem cell research, regulatory support for innovative therapies, and personalized medicine approaches.

The forecast of 7.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of gene therapies for juvenile macular degeneration by inflating prices of retinal gene vectors and specialized optical coherence tomography devices developed in the UK and Switzerland, resulting in progressive vision loss and higher pediatric ophthalmology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Juvenile Macular Degeneration Treatment Market Segmented?

1) By Type: Wet Age-Related Macular Degeneration, Dry Age-Related Macular Degeneration

2) By Treatment: Devices, Drugs, Surgery

3) By Application: Vision Preservation, Disease Management, Symptom Relief, Preventive Care, Clinical Trials

4) By Sales Channel: Hospitals, Ambulatory Surgical Centres, Other Sales Channel

Subsegments:

1) By Wet Age-Related Macular Degeneration: Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapy, Photodynamic Therapy (PDT), Laser Therapy

2) By Dry Age-Related Macular Degeneration: nutritional supplements, Gene Therapy, stem cell therapy

What Is Driving The Juvenile Macular Degeneration Treatment Market? Rising Retinal Disorders Driving The Growth Of The Market Due To Increasing Diabetes Prevalence

The increasing prevalence of retinal disorders is expected to propel the growth of the juvenile macular degeneration treatment market going forward. Retinal disorders refer to a group of conditions that affect the retina, the light-sensitive layer at the back of the eye, leading to vision impairment or loss. Retinal disorders are increasing due to the rising prevalence of diabetes, leading to conditions such as diabetic retinopathy that damage the retina over time. Juvenile macular degeneration treatments enhance retinal disorder management by preserving vision through early intervention, making them crucial for young patients. For instance, in November 2024, according to the report published by Retina Australia, an Australia-based non-profit organization, in Australia, approximately 19,000 individuals, or about 1 in 1,380 people, are estimated to be living with an inherited retinal disease (IRD). Furthermore, according to the National Eye Institute, a US-based institute of health, the number of Americans with advanced age-related macular degeneration (AMD) is expected to increase from the current 2.1 million to 3.7 million by 2030. Therefore, the increasing prevalence of retinal disorders is driving the growth of the juvenile macular degeneration treatment industry.

Who Are The Major Players In The Global Juvenile Macular Degeneration Treatment Market?

Major companies operating in the juvenile macular degeneration treatment market are F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, AbbVie Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Santen Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Samsung Bioepis Co. Ltd., Spark Therapeutics Inc., Polpharma Biologics S.A., OrCam Technologies Ltd., Alkeus Pharmaceuticals Inc., Bioeq AG, NuEyes Technologies Inc., Coherus BioSciences Inc., eSight Eyewear Inc., MeiraGTx Holdings plc, Kubota Pharmaceutical Holdings Co. Ltd.

What Are The Key Trends Of The Global Juvenile Macular Degeneration Treatment Market? Innovative Gene Therapies Advance Treatment Options For Stargardt Disease

Major companies operating in the juvenile macular degeneration treatment market are focusing on developing innovative solutions, such as dual adeno-associated viral (AAV) vectors, to enhance gene therapy delivery and improve treatment efficacy for patients with juvenile macular degeneration. A dual adeno-associated viral (AAV) vector is a gene therapy approach that uses two AAV vectors to deliver large therapeutic genes that exceed the packaging capacity of a single AAV. For instance, in March 2025, SpliceBio, a Spain-based biotechnology company, announced the first patient dosing in its Phase 1/2 ASTRA study for SB-007, a dual AAV vector gene therapy designed to restore full-length ABCA4 protein expression. The therapy aims to provide a potential treatment for juvenile macular degeneration (stargardt disease), an inherited retinal disorder with no approved treatments, by addressing all patients regardless of their mutations. This milestone marks a significant step toward developing effective gene therapies for rare retinal diseases.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Juvenile Macular Degeneration Treatment Market? Astellas Pharma Acquires IVERIC Bio To Expand Ophthalmology And Retinal Disease Treatments

In July 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired IVERIC bio Inc. for an undisclosed amount. Through this acquisition, Astellas aims to strengthen its ophthalmology portfolio, accelerate the development of innovative treatments for retinal diseases, and expand its capabilities in gene therapy and complement inhibition, particularly for conditions such as stargardt disease and geographic atrophy. IVERIC bio Inc. is a US-based company focused on developing treatments for juvenile macular degeneration, specifically Stargardt disease.

What Is The Regional Outlook For The Global Juvenile Macular Degeneration Treatment Market?

North America was the largest region in the juvenile macular degeneration treatment market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Juvenile Macular Degeneration Treatment Market?

The juvenile macular degeneration treatment market consists of revenues earned by entities by providing services such as vision therapy, low vision rehabilitation, genetic counseling, nutritional counseling, and psychological support for vision loss management. The market value includes the value of related goods sold by the service provider or included within the service offering. The juvenile macular degeneration (JMD) treatment market also includes sales of prescription eyewear, low vision aids, braille displays, specialty lighting devices, and dietary supplements for eye health. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Juvenile Macular Degeneration Treatment Industry?

The juvenile macular degeneration treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the juvenile macular degeneration treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Juvenile Macular Degeneration Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.39 billion
Revenue Forecast In 2034	$1.87 billion
Growth Rate	CAGR of 7.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The juvenile macular degeneration treatment market covered in this report is segmented – 1) By Type: Wet Age-Related Macular Degeneration, Dry Age-Related Macular Degeneration 2) By Treatment: Devices, Drugs, Surgery 3) By Application: Vision Preservation, Disease Management, Symptom Relief, Preventive Care, Clinical Trials 4) By Sales Channel: Hospitals, Ambulatory Surgical Centres, Other Sales Channel Subsegments: 1) By Wet Age-Related Macular Degeneration: Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapy, Photodynamic Therapy (PDT), Laser Therapy 2) By Dry Age-Related Macular Degeneration: Nutritional Supplements, Gene Therapy, Stem Cell Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Request for Sample
Customization Scope	Explore Purchase Options
Pricing And Purchase Options

1. Executive Summary

2. Juvenile Macular Degeneration Treatment Market Characteristics

3. Juvenile Macular Degeneration Treatment Market Trends And Strategies

4. Juvenile Macular Degeneration Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Juvenile Macular Degeneration Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Juvenile Macular Degeneration Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Juvenile Macular Degeneration Treatment Market Growth Rate Analysis

5.4. Global Juvenile Macular Degeneration Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Juvenile Macular Degeneration Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Juvenile Macular Degeneration Treatment Total Addressable Market (TAM)

6. Juvenile Macular Degeneration Treatment Market Segmentation

6.1. Global Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Wet Age-Related Macular Degeneration

Dry Age-Related Macular Degeneration

6.2. Global Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Devices

Drugs

Surgery

6.3. Global Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vision Preservation

Disease Management

Symptom Relief

Preventive Care

Clinical Trials

6.4. Global Juvenile Macular Degeneration Treatment Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Ambulatory Surgical Centres

Other Sales Channel

6.5. Global Juvenile Macular Degeneration Treatment Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapy

Photodynamic Therapy (PDT)

Laser Therapy

6.6. Global Juvenile Macular Degeneration Treatment Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nutritional Supplements

Gene Therapy

Stem Cell Therapy

7. Juvenile Macular Degeneration Treatment Market Regional And Country Analysis

7.1. Global Juvenile Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Juvenile Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Juvenile Macular Degeneration Treatment Market

8.1. Asia-Pacific Juvenile Macular Degeneration Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Juvenile Macular Degeneration Treatment Market

9.1. China Juvenile Macular Degeneration Treatment Market Overview

9.2. China Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Juvenile Macular Degeneration Treatment Market

10.1. India Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Juvenile Macular Degeneration Treatment Market

11.1. Japan Juvenile Macular Degeneration Treatment Market Overview

11.2. Japan Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Juvenile Macular Degeneration Treatment Market

12.1. Australia Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Juvenile Macular Degeneration Treatment Market

13.1. Indonesia Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Juvenile Macular Degeneration Treatment Market

14.1. South Korea Juvenile Macular Degeneration Treatment Market Overview

14.2. South Korea Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Juvenile Macular Degeneration Treatment Market

15.1. Western Europe Juvenile Macular Degeneration Treatment Market Overview

15.2. Western Europe Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Juvenile Macular Degeneration Treatment Market

16.1. UK Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Juvenile Macular Degeneration Treatment Market

17.1. Germany Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Juvenile Macular Degeneration Treatment Market

18.1. France Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Juvenile Macular Degeneration Treatment Market

19.1. Italy Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Juvenile Macular Degeneration Treatment Market

20.1. Spain Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Juvenile Macular Degeneration Treatment Market

21.1. Eastern Europe Juvenile Macular Degeneration Treatment Market Overview

21.2. Eastern Europe Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Juvenile Macular Degeneration Treatment Market

22.1. Russia Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Juvenile Macular Degeneration Treatment Market

23.1. North America Juvenile Macular Degeneration Treatment Market Overview

23.2. North America Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Juvenile Macular Degeneration Treatment Market

24.1. USA Juvenile Macular Degeneration Treatment Market Overview

24.2. USA Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Juvenile Macular Degeneration Treatment Market

25.1. Canada Juvenile Macular Degeneration Treatment Market Overview

25.2. Canada Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Juvenile Macular Degeneration Treatment Market

26.1. South America Juvenile Macular Degeneration Treatment Market Overview

26.2. South America Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Juvenile Macular Degeneration Treatment Market

27.1. Brazil Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Juvenile Macular Degeneration Treatment Market

28.1. Middle East Juvenile Macular Degeneration Treatment Market Overview

28.2. Middle East Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Juvenile Macular Degeneration Treatment Market

29.1. Africa Juvenile Macular Degeneration Treatment Market Overview

29.2. Africa Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Juvenile Macular Degeneration Treatment Market Competitive Landscape And Company Profiles

30.1. Juvenile Macular Degeneration Treatment Market Competitive Landscape

30.2. Juvenile Macular Degeneration Treatment Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Juvenile Macular Degeneration Treatment Market Other Major And Innovative Companies

31.1. Astellas Pharma Inc.

31.2. Biogen Inc.

31.3. Santen Pharmaceutical Co. Ltd.

31.4. Teva Pharmaceutical Industries Ltd.

31.5. Samsung Bioepis Co. Ltd.

31.6. Spark Therapeutics Inc.

31.7. Polpharma Biologics S.A.

31.8. OrCam Technologies Ltd.

31.9. Alkeus Pharmaceuticals Inc.

31.10. Bioeq AG

31.11. NuEyes Technologies Inc.

31.12. Coherus BioSciences Inc.

31.13. eSight Eyewear Inc.

31.14. MeiraGTx Holdings plc

31.15. Kubota Pharmaceutical Holdings Co. Ltd.

32. Global Juvenile Macular Degeneration Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Juvenile Macular Degeneration Treatment Market

34. Recent Developments In The Juvenile Macular Degeneration Treatment Market

35. Juvenile Macular Degeneration Treatment Market High Potential Countries, Segments and Strategies

35.1 Juvenile Macular Degeneration Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Juvenile Macular Degeneration Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Juvenile Macular Degeneration Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Juvenile Macular Degeneration Treatment Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Juvenile Macular Degeneration Treatment Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Juvenile Macular Degeneration Treatment Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Juvenile Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Juvenile Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: F. Hoffmann-La Roche Ltd. Financial Performance

Table 78: Bayer AG Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: AbbVie Inc. Financial Performance

Table 81: Regeneron Pharmaceuticals Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Juvenile Macular Degeneration Treatment Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Juvenile Macular Degeneration Treatment Market, Sub-Segmentation Of Wet Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Juvenile Macular Degeneration Treatment Market, Sub-Segmentation Of Dry Age-Related Macular Degeneration, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Juvenile Macular Degeneration Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Juvenile Macular Degeneration Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Juvenile Macular Degeneration Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Juvenile Macular Degeneration Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Juvenile Macular Degeneration Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 78: Bayer AG Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: AbbVie Inc. Financial Performance

Figure 81: Regeneron Pharmaceuticals Inc. Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Age-Related Macular Degeneration Global Market Report 2025 – By Type (Wet Age-Related Macular Degeneration (AMD), Dry Age-Related Macular Degeneration (AMD)), By Drug (Eylea, Lucentis, Avastin, Other Products), By Route ...

Macular Edema and Macular Degeneration Global Market Report 2025 – By Treatment Type (Drug Therapy, Laser Treatment), By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Dege...

Retinal Disorder Treatment Global Market Report 2025 – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Distribution ...

Ocular Inflammation Treatment Global Market Report 2025 – By Treatment Type (Immunosuppressant, Antivirals, Corticosteroids, Antibiotics, Analgesics, Monoclonal Antibodies, Antifungal, Cycloplegic), By Mode of Operation ...

Anemia And Other Blood Disorder Drugs Global Market Report 2025 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Di...

Ocular Hypertension Treatment Global Market Report 2025 – By Type (Intraocular Hypertension, Glaucoma), By Route of Administration (Oral, Parenteral, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Phar...

Retinal Biologics Global Market Report 2025 – By Drug Class (Vascular Endothelial Growth Factor (VEGF)-A Antagonist, Tumor Necrosis Factor (TNF)-A Inhibitor), By Indication (Macular Degeneration, Diabetic Retinopathy, Uv...

Frequently Asked Questions

What is the definition of the Juvenile Macular Degeneration Treatment market?

How will the Juvenile Macular Degeneration Treatment market drivers and restraints affect the market dynamics? What forces will shape the Juvenile Macular Degeneration Treatment industry going forward?

The market major growth driver - Rising Retinal Disorders Driving The Growth Of The Market Due To Increasing Diabetes Prevalence. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Juvenile Macular Degeneration Treatment market?

The juvenile macular degeneration treatment market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing prevalence of genetic eye disorders, increasing investment in ophthalmic research, increasing focus on pediatric eye care, rising prevalence of vision impairment among children, and growing integration of artificial intelligence in eye care diagnostics. The juvenile macular degeneration treatment market size is expected to see strong growth in the next few years. It will grow to " $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to a rise in the geriatric population, a rise in ophthalmic biotechnology startups, an increasing focus on targeted drug delivery systems, an increasing number of clinical trials, and increasing investment in gene therapy. Major trends in the forecast period include advancements in genetic testing, the development of gene therapies, stem cell research, regulatory support for innovative therapies, and personalized medicine approaches. For further insights on this market, request a sample here

How is the Juvenile Macular Degeneration Treatment market segmented?

The juvenile macular degeneration treatmentmarket covered in this report is segmented –
1) By Type: Wet Age-Related Macular Degeneration; Dry Age-Related Macular Degeneration
2) By Treatment: Devices; Drugs; Surgery
3) By Application: Vision Preservation; Disease Management; Symptom Relief; Preventive Care; Clinical Trials
4) By Sales Channel: Hospitals; Ambulatory Surgical Centres; Other Sales Channel Subsegments:
1) By Wet Age-Related Macular Degeneration: Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapy; Photodynamic Therapy (PDT); Laser Therapy
2) By Dry Age-Related Macular Degeneration: Nutritional Supplements; Gene Therapy; Stem Cell Therapy For further insights on this market, request a sample here

Which region has the largest share of the Juvenile Macular Degeneration Treatment market? What are the other regions covered in the report?

North America was the largest region in the juvenile macular degeneration treatment market in 2024. The regions covered in the juvenile macular degeneration treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Juvenile Macular Degeneration Treatment market?

What are the key trends in the Juvenile Macular Degeneration Treatment market?

Major trends in this market include Innovative Gene Therapies Advance Treatment Options For Stargardt Disease. For further insights on this market, request a sample here.